Skip to main content

Table 1 Maternal and neonatal/infant primary and secondary outcomes

From: Effects of probiotics (Vivomixx®) in obese pregnant women and their newborn: study protocol for a randomized controlled trial

Measurement

Inclusion/randomization (14–20 weeks)

27–30 weeks

36–37 weeks

Delivery

1–3 days after delivery

3 months after delivery

6 months after delivery

9 months after delivery

Baseline questionnaire

X

       

Diet questionnaire

X

 

X

     

Weight (pregnant/mother)

X

X

X

 

X

X

X

X

Blood sample (pregnant/mother)

X

X

X

 

X

X

 

X

Blood pressure

X

X

X

     

Fecal sample (pregnant/mother)

X

X

X

 

X

X

X

X

Urine sample + vaginal swab

X

X

X

     

Pedometer

X

X

X

     

OGTT

X

X

      

Fecal sample – infant

    

X

X

X

X

Urine sample – infant

    

X

X

X

X

Newborn – umbilical cord blood sample

   

X

    

DEXA scanning

    

X

   

Breast milk sample

    

X

X

X

X

Newborn/child physical examination and anthropometric data

    

X

X

X

X

Question about urinary tract infections

X

X

X

     

Question about colic symptoms, breastfeeding, allergy and atopic dermatitis

     

X

X

X

  1. DEXA dual-energy X-ray absorptiometry, OGTT oral glucose tolerance test